'Evaluating SPR array imaging for glycobiology'

Lead Research Organisation: University of Manchester
Department Name: Chemistry

Abstract

Whilst carbohydrate structure and recognition are clearly central to biology, our appreciation of their structure and function is still rudimentary compared to proteins and nucleic acids. It has been estimated that around 2% of the human genome is dedicated to glyco-active enzymes (up to 6% in plants) and that over 70% of all proteins in man are glycosylated. In turn this has led to a need for analysis of larger numbers of glycan structures, and their cognate binding proteins, which has provided the impetus for the development of new technologies with high-throughput potential. Latterly, glycoscientists have identified carbohydrate microarrays (glycoarrays) as a key tool for the high-throughput studies that are necessary to understand this complex area of biology. The purpose of this study is to evaluate new methods with which to analyse carbohydrate-active enzymes based on integrated, chip-based surface plasmon resonance spectroscopy-mass spectrometry.

Technical Summary

The purpose of this study is to evaluate new methods with which to analyse carbohydrate-active enzymes based on integrated, chip-based surface plasmon resonance spectroscopy-mass spectrometry. Specifically, alkyl-PEG self-assembled monolayers on gold chips will be used to present carbohydrates for biotransformations. Reactions will be monitored directly by MALDI-tof mass spectrometry, or product formation will be assessed indirectly by lectin detection and surface plasmon resonance spectroscopy.

Publications

10 25 50
 
Description This was a short feasibility study to investigate the application of surface plasmon resonance spectroscopy of glycan arrays. the method was succesfull but issues of data-handling were identified.
Exploitation Route The method will need some significant input in terms of data handling, which was beyond this proof of concept study
Sectors Aerospace, Defence and Marine,Environment,Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description This was just a feasibility study - given the problems encountered a more significant effort will be required to bring this technique to the market.